First AD

Second AD

Shravan Kandula, MD, reviews findings from the DIPPER trial, which is investigating adjuvant PD-1 blockade with camrelizumab in patients with nasopharyngeal carcinoma.

Phase 3 DIPPER Trial: Adjuvant PD-1 Blockade with Camrelizumab

Video content above is prompted by the following:

Please highlight the study design, efficacy, and safety data of the phase 3 DIPPER trial.

What are your thoughts on the data and how might this impact the current treatment landscape?

Head & Neck Cancers

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer. 

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Clinical Advances in Nasopharyngeal Carcinoma

Yale Cancer Center